注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
本基金旨在主要(即至少70%之資產)透過投資受惠於人口結構改變的全球各地公司股票組合,以達成長期資本增長。投資標的包含但不限於醫療保健與受惠於人口老化之預期壽命成長及新興市場日漸富裕的消費行業。少於30%的本基金資產得投資於新興市場。投資經理人投資之重點將較集中於部分特定公司股票,故投資組合分散程度較低。如公開說明書「1.3.2(a)富達永續發展投資框架」一節所述,基金淨資產至少50%將投資於被視為保有永續發展特色之證券。本基金將持續考慮多種環境及社會特色。本基金採主動式管理。在選擇本基金之投資且為監控風險之目的時,投資經理人將參考MSCI ACWI Index (「指數」),因為該指數之成分代表了本基金所投資之公司類型。本基金之表現可以根據其指數進行評估。投資經理人相較於該指數,具有廣泛的裁量權。詳請參富達基金部分公開說明書中譯本。
名稱 | 主旨 | 成立於 | 直至 |
---|---|---|---|
Oliver Hextall | Portfolio Manager | 2019 | now |
Aneta Wynimko | Analyst | 2019 | now |
Alex Gold | Portfolio Manager | 2019 | now |
自傳 | Alex joined Fidelity as an analyst in September 2010 after having completed his ACA accountancy qualification at PricewaterhouseCoopers (PwC). He covered a variety of sectors including energy, medical technology and European large cap banks. He was promoted to a portfolio manager in July 2017 and took over management of the Global Healthcare Fund in October 2017, a move which was as a result of his strong performance metrics among the analyst group. | ||
Aneta Wynimko | Analyst | 2015 | 2019 |
Velislava Dimitrova | - | 2017 | 2019 |
Hilary Natoff | Portfolio Manager | 2012 | 2017 |
自傳 | Hilary Natoff has been with Fidelity since 2000, having previously worked at Henderson Investors. She has been an analyst in the pharmaceutical sector since 2002 and became sector leader for European Healthcare in 2004. She assumed management of the European Health Pilot Fund in June 2004. | ||
Nicola Stafford | Member | 2012 | 2015 |
自傳 | Ms. Stafford has worked as a research analyst and portfolio manager since joining Fidelity Investments in 2005. |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核